In the January 2020 edition of STAT News was a news release from 215 biopharma CEOs and industry leaders. The news release leverages 2020 as the beginning of “the dawn of a golden age of medicine [which] will soon have the ability to treat and cure diseases that have long been untreatable and incurable.” [...]
A primary goal of rheumatologists remains alleviating the pain, stiffness and tenderness that mark rheumatoid arthritis (RA). Yet in an era marked by a significant increase in self-injection options, it has become crucial for these HCPs to understand just how well their rheumatology patients are self-administering their medications. Currently, most RA patients undergo a [...]
Millions of patients worldwide living with rare, debilitating conditions are benefiting from developments in biopharmaceuticals and complex chemical entities as well as novel approaches to drug delivery. For example, many therapeutics administered in a subcutaneous injection are suitable for at-home administration by patients themselves, rather than in a healthcare facility. This includes wearable injection [...]
Chronic illnesses are on the rise, which means there are more and more patients who need to self-inject treatments at home. The problem is that patients who lack confidence in using their drug-delivery device or are inadequately familiar with the device tend to use it incorrectly and may not be receiving the full dose [...]
Participants in a study by the company Noble show that the vast majority of patients—92%—would prefer to bring home a training device to practice with prior to starting self-injection. Noble creates trainers for autoinjectors intended to increase patient confidence and autonomy with self-managed treatments. Watch full clip>
Joe Reynolds leverages the knowledge of the pharmaceutical and medical device industries to derive insights and maximize value for all members of the Noble healthcare team. His experience includes work with various consumer and healthcare brands. Joe holds a Bachelor of Science in Business from the University of Central Florida, a Master’s of Science [...]
Ensuring that diabetes patients correctly administer their insulin or glucagon is a priority for prescribers and patients alike. Keeping tabs on the extent to which patients are (or are not) taking their medications as prescribed, however, is increasingly complicated due to technical innovations in drug delivery. Read full article >
Across the US, half of all adults live with a chronic disease – and many of them are prescribed a self-injectable therapy to help manage their condition. As the patient population and demand for self-injection treatments continue to grow, so will the number of patients being introduced to self-injection drug delivery devices. This growing [...]
Desperate for relief, many people living with psoriasis and atopic dermatitis rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting task—evidenced by the 45% of patients who skip or altogether avoid injections due to anxiety or fear—proper training and onboarding is critical. Even more alarming is that nearly [...]
ORLANDO – May 1, 2019 – Noble, the global leader in medical device training solutions, patient onboarding strategies and multisensory product development for the world’s top pharmaceutical brands, unveiled today a new injection training platform based on 1 mL and 2.25 mL YpsoMate devices to help improve patient onboarding and health outcomes. Given that [...]